Clinical Trial Results: Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing memantine to prevent cognitive late effects in children receiving cranial radiation for localized brain tumors; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniopharyngioma
• Ependymoma
• Germ Cell Tumor
• Glioma of the Brain

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Glioma of Brain, Craniopharyngioma | Phase 2 | Status: COMPLETED | Results posted: 2026-06-23